Dr. Wang is Executive Director at the Foundation for Applied Molecular Evolution and a leading translational neurotrauma researcher with 35+ years of experience. He co-discovered FDA/EMA-cleared TBI biomarkers (UCH-L1/GFAP), holds 15 patents, authored 300+ publications, and founded CNS biotech companies advancing and therapeutics in TBI and and neurodegeneration. He is also Editor-in-Chief of the journal Concussion.